Search Results - "Favagrossa, Monica"
-
1
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
Published in Pharmacological research (01-08-2023)“…Evidence that Huntington's disease (HD) is characterized by impaired cholesterol biosynthesis in the brain has led to strategies to increase its level in the…”
Get full text
Journal Article -
2
A cutting-edge approach based on UHPLC-MS to simultaneously investigate oxysterols and cholesterol precursors in biological samples: Validation in Huntington's disease mouse model
Published in Talanta open (01-08-2024)“…•Reduced cholesterol biosynthesis in the brain is an early dysfunction in Huntington's disease.•Liquid chromatography-mass spectrometry is a powerful technique…”
Get full text
Journal Article -
3
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease
Published in Journal of controlled release (10-02-2021)“…Supplementing brain cholesterol is emerging as a potential treatment for Huntington's disease (HD), a genetic neurodegenerative disorder characterized, among…”
Get full text
Journal Article -
4
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
Published in Molecular psychiatry (01-12-2022)“…Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder that affects millions of people worldwide. AD pathogenesis is intricate. It primarily…”
Get full text
Journal Article -
5
I07 A new generation of brain-targeted nanoparticles for cholesterol delivery in huntington’s disease: kinetics, drug release and behavioral effects in mouse models
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2021)“…BackgroundCholesterol (Chol), an essential molecule for brain function, is produced locally in the brain as the blood-brain barrier (BBB) prevents its uptake…”
Get full text
Journal Article -
6
D14 Plasma levels of 24S-hydroxycholesterol are reduced in Huntington disease subjects: preliminary results of a 2-year longitudinal study
Published in Journal of neurology, neurosurgery and psychiatry (12-09-2022)“…ObjectivesBrain cholesterol is produced in situ and its turn-over is ensured by the conversion into 24S-hydroxycholesterol (24-OHC) which can cross the…”
Get full text
Journal Article -
7
I17 Sustained benefits of brain-permeable cholesterol-loaded nanoparticles in zQ175DN mouse model
Published in Journal of neurology, neurosurgery and psychiatry (12-09-2022)“…BackgroundHuntington’s disease (HD) is associated with reduced synthesis of brain cholesterol (chol) and mounting evidence highlights the concept that…”
Get full text
Journal Article -
8
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington’s Disease
Published in ACS chemical neuroscience (05-02-2020)“…The current pharmacological treatment of Huntington’s disease (HD) is palliative, and therapies to restore functions in patients are needed. One of the…”
Get full text
Journal Article